MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2337/dc24-2039

Медицинская библиотека · Diabetes care · 2025

Short-term Metformin Protects Against Glucocorticoid-Induced Toxicity in Healthy Individuals: A Randomized, Double-Blind, Placebo-Controlled Trial.

Thierry Susanne, Peterson Caspar Joyce, Pfammatter Stéphanie, Tardio Patricia Arroyo, Meier Christian, Delko Tarik, Iten Vasco, Zuern Christine S, Kühne Michael, Epstein Michael, Othman Alaa, Zamboni Nicola, Reinisch Isabel, Ghosh Adhideb, Wolfrum Christian, Seelig Eleonora

СтатьяРандомизированное исследованиеПеревод пока не подготовлен

Аннотация

OBJECTIVE

Glucocorticoids (GCs) are potent anti-inflammatory drugs, but strategies to prevent side effects are lacking. We investigated whether metformin could prevent GC-related toxicity and explored the underlying mechanisms.

RESEARCH DESIGN AND

METHODS

This single-center, randomized, placebo-controlled, double-blind, crossover trial compared metformin with placebo during high-dose GC treatment in 18 lean, healthy, male study participants. The trial was conducted at the University Hospital Basel, Basel, Switzerland. Participants received prednisone 30 mg/day in combination with metformin or placebo for two 7-day periods (1:1 randomization). The primary outcome, change in insulin sensitivity, was assessed using a two-sided paired t test. Before and after each study period, we conducted a mixed-meal tolerance test, blood metabolomics, and RNA sequencing of subcutaneous adipose tissue biopsy specimens.

RESULTS

Metformin improved insulin sensitivity as assessed by the Matsuda index (n = 17; mean change -2.73 ± 3.55 SD for placebo, 2.21 ± 3.95 for metformin; mean difference of change -4.94 [95% CI, -7.24, -2.65]; P < 0.001). Metabolomic and transcriptomic analyses revealed that metformin altered fatty acid flux in the blood and downregulated genes involved in fatty acid synthesis in adipose tissue. Metformin reduced markers of protein breakdown and bone resorption. Furthermore, metformin downregulated genes responsible for AMPK inhibition and affected glucagon-like peptide 1 and bile acid metabolism.

CONCLUSIONS

Metformin prevents GC-induced insulin resistance and reduces markers of dyslipidemia, myopathy, and, possibly, bone resorption through AMPK-dependent and -independent pathways.

Для цитирования: Thierry Susanne, Peterson Caspar Joyce, Pfammatter Stéphanie, Tardio Patricia Arroyo, Meier Christian, Delko Tarik, Iten Vasco, Zuern Christine S, Kühne Michael, Epstein Michael, Othman Alaa, Zamboni Nicola, Reinisch Isabel, Ghosh Adhideb, Wolfrum Christian, Seelig Eleonora. Short-term Metformin Protects Against Glucocorticoid-Induced Toxicity in Healthy Individuals: A Randomized, Double-Blind, Placebo-Controlled Trial.. Diabetes care. 2025. DOI: 10.2337/dc24-2039.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.